Clare Omatseye, founder and managing director of JNC International Limited and founder of Vaccipharm Limited, has been honoured with the highly coveted FATE Model Entrepreneur (FME) Award 2025, earning resounding applause from industry leaders and admirers across Nigeria’s healthcare sector.
The award, presented by the FATE Foundation, recognises exceptional entrepreneurs who have demonstrated vision, resilience, and transformative impact in their fields. Omatseye’s selection comes as no surprise to many who have followed her outstanding 35-year journey in strengthening Nigeria’s healthcare ecosystem.
Adenike Adeyemi, executive director of FATE Foundation, presented the award alongside Bambo Adebowale, dean and director of the FATE School, and Toyin Bakare, president of the FATE Alumni Executive Committee. Together, they underscored Omatseye’s contributions to building a stronger health system through innovation and strategic leadership.
Omatseye’s career stands out for its consistency and depth. Over the last three and a half decades, she has championed access to quality healthcare technologies, supported capacity development, and advanced pharmaceutical distribution across Nigeria and West Africa—all with a reputation for diligence, integrity, and commitment.
Her work through JNC International has reshaped healthcare infrastructure, equipping hospitals with modern medical technologies and improving service delivery in critical areas such as diagnostics, surgery, and intensive care. Through Vaccipharm Limited, she has further contributed to strengthening supply chains for vaccines and biologics, an effort widely acknowledged during the COVID-19 era.
Colleagues and stakeholders have described her recognition as long overdue, calling it a “well-deserved honour” for a woman who has “paid her dues” in healthcare advocacy and enterprise development. Many applauded her consistency, discipline, and ability to inspire younger professionals within and beyond the pharmaceutical space.
Chairman of the Pharma West Africa Leaders Club, Pharm. Ahmed Yakasai also celebrated her achievements, praising her as a role model who embodies the values of excellence, service, and leadership. They noted that her contributions continue to shape policy discussions and investment decisions in the region’s healthcare sector.
In her acceptance remarks, Omatseye expressed gratitude to the FATE Foundation for the recognition and reaffirmed her commitment to driving systems-level improvements in healthcare. She dedicated the award to her team, industry partners, and the broader community working to advance access to care.
As congratulations continue to pour in, Omatseye’s FME Award reinforces her standing as one of Nigeria’s most influential healthcare entrepreneurs—an enduring force whose impact will continue to resonate for years to come.
